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A morphogenetic EphB/EphrinB code controls
hepatopancreatic duct formation
M. Ilcim Thestrup1, Sara Caviglia 1, Jordi Cayuso 2, Ronja L.S. Heyne1, Racha Ahmad1,
Wolfgang Hofmeister 1,3,4, Letizia Satriano5, David G. Wilkinson 2, Jesper B. Andersen 5 &
Elke A. Ober 1*
The hepatopancreatic ductal (HPD) system connects the intrahepatic and intrapancreatic
ducts to the intestine and ensures the afferent transport of the bile and pancreatic enzymes.
Yet the molecular and cellular mechanisms controlling their differentiation and morpho-
genesis into a functional ductal system are poorly understood. Here, we characterize HPD
system morphogenesis by high-resolution microscopy in zebraﬁsh. The HPD system differ-
entiates from a rod of unpolarized cells into mature ducts by de novo lumen formation in a
dynamic multi-step process. The remodeling step from multiple nascent lumina into a single
lumen requires active cell intercalation and myosin contractility. We identify key functions for
EphB/EphrinB signaling in this dynamic remodeling step. Two EphrinB ligands, EphrinB1 and
EphrinB2a, and two EphB receptors, EphB3b and EphB4a, control HPD morphogenesis by
remodeling individual ductal compartments, and thereby coordinate the morphogenesis of
this multi-compartment ductal system.
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A critical step in establishing a functional digestive systemis the connection of the accessory organs to the intestine.During development, the hepatopancreatic ductal (HPD)
system connects the liver, gallbladder (GB) and pancreas to the
digestive tract. The HPD system is essential for food processing and
uptake of nutrients, as it transports the bile produced in the liver, as
well as pancreatic enzymes and electrolytes to the intestine, but little
is known about how the HPD develops. It is a multi-component
system consisting of the extrahepatic duct (EHD), cystic duct (CD),
common bile duct (CBD) and extrapancreatic duct (EPD; Fig. 1f)1.
A subgroup including EHD, CD and CBD, as well as the gallbladder
GB are known as the extrahepatic biliary ducts (EHB). The CBD
coming from the liver and the EPD from the pancreas converge
into the hepatopancreatic ampulla (HPA), also known as Ampulla
of Vater in humans, connecting the HPD system to the intestine.
This organization and morphology of the HPD system is conserved
between ﬁsh and amniotes, however, in mammals the EHDs are
commonly referred to as right or left ducts and connecting common
duct, and the EPD as pancreatic duct1,2. Congenital or envir-
onmentally caused malformation of the HPD, such as ductal atresia
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Fig. 1 The HPD system forms by de novo tubulogenesis. a The forming HPD is visualized by pan-endodermal Tg(Xla.Eef1a1:GFP) (magenta) and ZO-1 (gray)
labels the ﬁrst junctional aggregates in the HPD primordium (blue arrow) at 46 hpf. b Ductal endoderm expression of Anxa4 (magenta) and apical aPKC
(gray) visualize HPD morphology and nascent microlumina within the prospective CBD and EPD (n= 17, N= 3). c The HPD system elongates and the
gallbladder anlage (yellow arrow) becomes detectable at 52 hpf. The immature EHB and HPA lumina show gaps and luminal loops compared to the EPD
exhibiting a continuous immature lumen (n= 21, N= 3). The HPA connects at two points (green arrows). d At 60 hpf, all ductal compartments and a
sphere-like gallbladder display a continuous emerging lumen, including a single connection of the HPA (green arrow), but excluding the EHD (n= 29, N=
2). See also Supplementary Movie 1. e Along organ growth, the HPD tubes start bending from 72 hpf. The emerging lumen formed in the HPD system is
continuous and connected to both IHD and IPD luminal network (n= 11, N= 2) f transgenic keratin18:GFP expression visualizes the compact EHB and IHD
at 5 dpf (n= 13, N= 4), see also Supplementary Movie 8. Schematic overviews of HPD differentiation (a–f): starting with junctional aggregates and
resulting in a continuous lumen spanning the HPD system. From 52 hpf individual HPD compartments are distinguishable: extrahepatic duct (EHD, pink);
cystic duct (CD, red); gallbladder (GB, yellow); common bile duct (CBD, orange); extrapancreatic duct (EPD, blue); hepatopancreatic ampula (HPA, green).
Scale bars: a–f= 10 μm. g Lumen length quantiﬁcation of the differentiating CBD between 48 and 72 hpf. h–j At 5 dpf, cortical actin indicates open lumina
in the wild-type EHD, CBD and EPD; scale bars= 10 μm. Magniﬁed cross-sections show open lumina (asterisk) of indicated ductal domains (yellow lines);
scale bars= 5 μm. Error bars show SEM; n= sample number, N= number of experiments. Source data are provided as a Source Data ﬁle
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caused by duct obstruction or paucity compromise organ function
and cause chronic inﬂammation3–6. Pancreatobiliary junction
malformations can result in a two-way reﬂux of bile and pancreatic
juice, leading to inﬂammation and subsequently malignant trans-
formation7. This underscores the importance of establishing the
ductal compartments and their junctions, however, the causes of
congenital HPD malformations are largely unknown.
HPD progenitors arise from an endodermal cell population
located between the liver and pancreas anlagen. In mouse, this
population co-expresses transcription factors Sox17 and Pdx1,
with Sox17 being essential for EHB duct formation8. The latter
acts in concert with other transcription factors, including Hes1,
Hnf6, Hnf1β and Hhex, whose deletion causes HPD malforma-
tions ranging from CBD enlargement and GB agenesis to repla-
cement with pancreatic or duodenal cells9–14. HPD progenitors in
zebraﬁsh are similarly located between the liver and pancreas and
express transcription factors Pdx1, Prox1, and Sox9b14,15. Intri-
guingly, lack of Sox9b leads to HPD malformation and ectopically
differentiating hepatic and pancreatic cells in the HPD15,16. Zeb-
raﬁsh mutants for mesodermal fgf10 exhibit similar cellular
plasticity in the HPD, indicating that mesoderm-endoderm
interactions are essential for HPD differentiation2,10. The
morphological emergence of the HPD coincides with the down-
regulation of Prox1 in HPD progenitors and membrane localisa-
tion of calcium binding protein AnnexinA4 (Anxa4)2,17. Although
the transcriptional network controlling HPD development is
emerging1,18, the morphogenetic events underlying duct differ-
entiation and their molecular regulators are largely unknown. Two
classic hypotheses describe the formation of the HPD either by
budding and invagination of the foregut epithelium, or by dif-
ferentiation from a solid tissue (e.g. cord) by subsequent vacuo-
lization and lumen formation. Histological analysis of human
embryonic tissue favors that a bile duct lumen buds from the
foregut, without transitioning through a solid tissue stage19. Due
to limited sample accessibility and developmental stages, current
understanding is incomplete and an in-depth analysis is necessary.
Eph receptor tyrosine kinases and their cognate Ephrin ligands
are regulators of diverse cellular functions, such as cell adhesion,
migration and proliferation, which are critical for organ morpho-
genesis and homeostasis20–22. EphB receptors interact primarily with
B-type transmembrane Ephrin ligands21. Their interaction can
uniquely trigger bidirectional signaling upon cell contact, with
EphB-expressing cells activating forward signaling and EphrinB-
bearing cells eliciting reverse signaling. Little is known about their
function in duct formation, whereas key roles in epithelial tissues
encompass localization of tight and adherens junctions proteins in
the Xenopus epithelial ectoderm23,24, cell sorting and positioning by
local actomyosin contractility at the Xenopus notochord-presomitic
mesoderm interface25, integrin clustering and extracellular matrix
assembly in zebraﬁsh somite boundary morphogenesis26. In the
context of inter-rhombomeric boundaries Ephs and Ephrins inhibit
cell intermingling and maintain boundary sharpness by promoting
actomyosin cable formation27,28. Co-expression of multiple Ephs
and Ephrins can confer signaling strength to activate cell detachment
during repulsion29. We previously showed that EphrinB1 and
EphB3b control directional liver progenitor migration into the liver
bud by a repulsion-based mechanism during early liver development
in zebraﬁsh30. Embryos with impaired EphrinB1 or EphB3b func-
tion exhibit dysmorphic HPD systems at later stages, suggesting a
hitherto unknown function for EphB/EphrinB signaling in HPD
morphogenesis.
Here, we present a high-resolution analysis of HPD tube
morphogenesis in zebraﬁsh. We show that a single lumen arises
by de novo lumen formation from a solid cord-like primordium
of unpolarized cells by a cord hollowing mechanism. This multi-
step process is driven by dynamic cell rearrangements, which
include cell intercalation, promoted by non-muscle myosin II
activity. Using genetic approaches, we provide evidence that these
processes are regulated by a morphogenetic EphB/EphrinB code
of multiple EphrinB ligands and EphB receptors controlling duct
differentiation and GB formation in a region-speciﬁc fashion.
Results
The HPD system forms by de novo lumen formation. To elu-
cidate the morphogenetic process of HPD formation we ﬁrst
investigated whether the ducts arise from an existing epithelial
sheet by a budding or wrapping mechanism, or from unpolarized
cells by de novo lumen formation31. Overall HPD morphology
was visualized by transgenic expression of pan-endodermal
XlaEef1a1:GFPs854, ductal keratin18:GFP (speciﬁc for hepatic
domains) or immunolabeling of Anxa4, recognized by the 2F11
antibody17. Cell polarity and lumen formation were assessed by
staining for atypical protein kinase C λ (aPKC) a member of the
PAR protein/aPKC complex that localizes to the apical mem-
brane of epithelial cells, or for the tight junction protein ZO-1.
Zebraﬁsh larvae were analyzed between 46 hours post fertilization
(hpf), when the HPD primordium emerges, and 5 days post
fertilization (dpf), when larvae start to feed (Fig. 1a–f). All HPD
compartments were assigned based on morphological landmarks.
The ﬁrst signs of tube formation are ZO-1 aggregates, which
appear randomly distributed along the central axis of the emer-
ging HPD primordium at 46 hpf (Fig. 1a), indicating that HPD
progenitors start to polarize. As early as 48 hpf, the CBD and
EPD are distinguishable as the ﬁrst domains of the HPD, at the
proximal end of the liver and pancreas, respectively (Fig. 1b).
Multiple, short and disconnected aPKC-positive apical structures
within both domains indicate the formation of immature luminal
pockets, reminiscent of microlumina described in the murine
pancreas32,33. In parallel, the HPD-to-gut connection is estab-
lished through nascent HPA apical pockets at multiple contact
points. Hence, all HPD ducts form de novo and not by a budding
process from the existing foregut epithelium (Fig. 1a, b). At 52
hpf, the GB primordium is detectable by dense group of aPKC
foci and its round morphology at the distal end of the CBD
(Fig. 1c), which later will connect to the EHD-CBD lumen via the
CD. At this stage, aPKC-positive apical pockets in the CBD and
the EPD form a semi-continuous nascent lumen, including gaps
and loops of parallel apical structures. The HPD is in most cases
connected to the gut at two points revealing that the HPA is still
immature (Fig. 1c). Between 52 and 60 hpf, duct maturation
results in the consolidation of a single continuous lumen con-
necting all compartments of the HPD, and duct lengthening
(Fig. 1d, g, Supplementary Movie 1). Finally, a reﬁned EHD
lumen connecting the HPD to the intrahepatic ductal (IHD)
network is clearly distinguishable by 72 hpf (Fig. 1e). Subse-
quently, the CBD and EPD bend as the connected organs grow
and their position within the body adjusts (Fig. 1e–g). Lumen
inﬂation of the HPD compartments occurs after 72 hpf and by 5
dpf (Fig. 1h–j, Supplementary Movie 8), likely due to apical
secretion of non-bile ﬂuids from the ductal epithelial cells and bile
secretion and transport from the liver starting at 5 dpf34. Notably,
aPKC staining before 5 dpf indicates HPD cell polarization and
lumen formation, however not necessarily an open patent lumen.
These ﬁndings show that HPD morphogenesis encompasses a
multi-step process, starting with scattered junctional aggregates,
which transition to form apical pockets and then fuse into
immature ductule morphology, including complex loop-shaped
apical structures, and ﬁnally remodel into a single central lumen
(Fig. 8c). This suggests that HPD tubes form from a solid cord-
like primordium, which undergoes de novo lumen formation
following a cord hollowing process.
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EphrinB1 and EphB3b control HPD morphogenesis. To elu-
cidate the molecular mechanisms controlling HPD morphogen-
esis, we focused on EphrinB1 and EphB3b as candidates, because
embryos with compromised function of either factor exhibit
dysmorphic HPD systems30 and EphB/EphrinB signaling governs
complex morphogenetic processes21. For the analyses, we used
ephrinb1nim26 mutants and generated an ephb3bnim27 genetic
mutant by Crispr/Cas9 genome editing (Supplementary Fig. 1).
We analyzed duct morphogenesis in ephrinb1 and ephb3b mutant
embryos at key stages of HPD formation by immunostaining for
Prox1, which labels hepatic and pancreatic progenitors, HNF4α
for differentiating hepatocytes, and aPKC visualizing apical
membranes (Fig. 2, Supplementary Fig. 2). Similar to controls,
aPKC-positive apical pockets emerge in ephrinb1 and ephb3b
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mutants at 48 hpf, suggesting that HPD progenitors form a HPD
primordium, polarize and initiate the formation of nascent tubes.
However, these structures appear slightly disorganized (Supple-
mentary Fig. 2a–c). By 52 hpf, the aPKC structures in the pro-
spective CBD and CBD-EPD-HPA junction are often associated
with more disruptions or loops in most ephrinb1 mutants com-
pared to wild-type (Fig. 2a, b). In contrast to wild-type and
ephrinb1 mutants, ephb3b mutants show aPKC loops also in the
EPD (Fig. 2a–c). The resolution of these immature lumina into a
single continuous lumen primordium in all HPD regions occurs
in wild-type by 60 hpf, however, is severely compromised in the
absence of EphrinB1 and EphB3b (Fig. 2d–f, Supplementary
Movie 1–3). Phenotype variability and penetrance were assessed
by quantiﬁcation of defect severity in the individual HPD
domains (Fig. 2h, Table 1, Supplementary Fig. 3). Notably, a
single nascent EPD lumen is resolved in most ephrinb1 mutants
(Fig. 2d–e), whereas this is still disorganized and web-like in
ephb3b embryos (Fig. 2f). ephrinb1;ephb3b double mutants
exhibit defects in all HPD domains similar to ephb3b (Fig. 2g, h,
Supplementary Movie 4), disregarding additive or synergistic
interactions and corroborating that EphB3b regulates morpho-
genesis of all HPD domains, while EphrinB1 mediates this pro-
cess only in a subset of domains. Unresolved loops, enlarged
aPKC/luminal structures, an amorph EHD or combinations of
these defects, are in both mutants frequently not remodeled by 72
hpf (Fig. 2i–k). Next, we asked whether the observed HPD defects
in ephrinb1 and ephb3b mutants persist when digestive activity is
starting at around 5 dpf. Anxa4 immunostainings showed dys-
morphic ductal compartments in both ephrinb1 and ephb3b
mutants, including signiﬁcantly altered EHD width and CBD
length, corresponding with earlier regional remodeling defects
(Fig. 2l–p, Supplementary Movies 8–10). In addition, ephb3b
mutants display larger GB and occasionally ectopic small ducts
branching from the EHD, CBD or EPD (30%, Fig. 2n).
Altogether these ﬁndings show that EphrinB1 and EphB3b
control HPD morphogenesis in a domain-speciﬁc manner:
EphrinB1 governs EHB tube morphogenesis, whereas EphB3b is
required for the formation of the entire HPD, including the EPD.
These only partially overlapping functions imply that HPD
morphogenesis may require additional EphrinB ligands and EphB
receptors.
EphrinB1 and EphB3b regulate dynamic CBD cell rearrange-
ments. Our analysis of lumen formation suggests that the HPD
system arises by de novo tube formation. To identify the
underlying cell behaviors and morphogenetic mechanism, we ﬁrst
examined the organization of the HPD, focusing on the CBD, by
co-staining for apical aPKC and pan-Cadherin, which localizes to
lateral membranes in epithelia and is expressed in the HPD
endoderm2. At 48 hpf, the HPD represents a solid cord consisting
of 3–4 cell layers (Fig. 3a), which transforms into a single-layered
epithelial duct by 60 hpf (Fig. 3b). Concomitantly, CBD length
increases signiﬁcantly between 52 and 60 hpf in controls, while in
both ephrinb1 and ephb3b mutants this extension fails to occur
during this time window (Fig. 3e). To distinguish whether CBD
tube formation is driven by active cell rearrangement and inter-
calation, or other mechanisms, such as apoptosis characteristic
for cavitation, we analyzed epithelial morphology.
At 60 hpf, when a continuous immature lumen extends
throughout the ductal system, epithelial cells are aligned in a
single layer with their apical domains forming the arising central
lumen (Fig. 3b). Cell shape analyses of individual cells with
luminal contribution in wild-type revealed a subset of teardrop-
shaped cells during duct remodeling stages (Supplementary
Fig. 4a). A teardrop-like morphology is a hallmark of radially
intercalating cells35, suggesting that those cells are actively
rearranging within the epithelium. In both ephrinb1 and ephb3b
mutants, epithelial organization is disrupted, marked by altered
irregular cell shapes and a multi-layered cell organization in areas
of immature apical loops (Fig. 3c, d). Ductal cells contributing to
ductal loops appear to have a single largely extended or multiple
apical domains (Fig. 3c). Cell shape analysis of the CBD revealed
Fig. 2 EphrinB1 and EphB3b control HPD remodeling in a spatiotemporal fashion. Compared to sibling controls at 52 hpf (a), emerging ducts are less
mature in ephrinb1 mutants with more disconnected luminal pockets in EHB and HPA, visualized by apical aPKC (white, n= 16, N= 3) (b). c HPD luminal
pockets are similarly disrupted in ephb3b mutants at 52 hpf, including the EPD (n= 17, N= 2). d Disconnected apical structures resolve into a single
immature lumen by 60 hpf in controls (n= 29, N= 2). e Disrupted remodeling causes enlarged aPKC structures and luminal loops in all EHB domains in
ephrinb1 mutants, while the EPD appears normal (n= 20, N= 2). f Resolution of apical structures in ephb3b mutants is compromised in all HPD domains,
including the EPD (n= 12, N= 1). g All HPD domains exhibit defective tube remodeling in ephrinb1;ephb3b mutants (n= 7). Schematics (d–f) show HPD
tube phenotypes at 60 hpf, see below for domain color-code. h Quantiﬁcation of domain-speciﬁc HPD tube formation defects in controls (n= 12), ephrinb1
(n= 14), ephb3b (n= 14) and ephrinb1;ephb3b (n= 7) mutants at 60 hpf. i–n Early domain-speciﬁc defects persist in ephrinb1 and ephb3b mutants at 72 hpf
(i–k; controls: n= 11, N= 2; ephrinb1: n= 5; ephb3b: n= 12, N= 1) and 5 dpf (l–n; control: n= 10, N= 2; ephrinb1: n= 6, N= 1; ephb3b: n= 10, N= 1). 30%
ephb3b mutants show in addition ectopic ducts (red; white arrow) bifurcating from the main HPD. Quantiﬁcation of EHD width (o) and CBD length (p) in
ephrinb1 and ephb3b mutants at 5 dpf. l–n Anxa4 (gray) visualizes the HPD system at 5 dpf. HPD domains are color-coded based on morphological
landmarks (e.g., HPA): EHD= pink; CD= red; gallbladder= yellow; CBD= orange; EPD= blue; HPA= green. Scale bar= 20 μm; n= sample number, N=
number of experiments; Statistical test: h= Fisher Exact, o, p= Student’s t-test. Errors bar show SEM; *p < 0,05, ***p < 0,001. Liver and pancreas stainings
for a–f and i–k are shown in Supplementary Fig. 2. Supplementary movies 1–4 and 8–10 show HPD phenotypes at 60 hpf and 5 dpf. Source data are
provided as a Source Data ﬁle
Table 1 Domain-speciﬁc classiﬁcation of HPD tube formation defects
HPD domain Score 1=mild defect
(ductal domains show only one of below defects)
Score 2= severe defect (ductal domains show
more than one of below defects)
Extrahepatic duct (EHD) Two branches, thinner, enlarged or gap More than two branches, loops
Gallbladder (GB) A bit longer/more inﬂated, gap, more than one branch attached
distally or enlarged cystic duct
Much longerinﬂated
Common bile duct (CBD) Long spike, loop, gap or more inﬂated Cystic, loops
Extrapancreatic duct (EPD) Long spike, loop, gap or more inﬂated Cystic, loops
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a clear increase of teardrop-shaped cells facing the apical lumen
in both ephrinb1 and ephb3b mutants at the expense of those with
opposite orientation and more columnar cells (Fig. 3f). In both
mutants, these changes are associated with an increase in cell
height (Fig. 3g). Impaired cell rearrangement in ephrinb1 and
ephb3b mutants results in a failure of CBD extension (Fig. 3e).
Finally, active cell rearrangement is supported by sparse labeling
of small clones with the membrane-tethered ﬂuorescent protein
lyn-Tomato in wild-type, revealing HPD cells extending small
ﬁlopodia-like protrusions, including several towards the forming
lumen (Supplementary Fig. 4b). Given the known role of EphB/
EphrinB signaling in cell proliferation21, we assessed its
contribution to HPD morphogenesis. Neither cell proliferation
rate nor overall HPD cell number are signiﬁcantly changed in
ephrinb1 and ephb3b mutants compared to controls (Supple-
mentary Fig. 6), indicating that EphrinB1 and EphB3b control
HPD morphogenesis mainly by alternative mechanisms.
Together these data indicate that scattered apical pockets remodel
and coalesce into a continuous nascent lumen by dynamic cell
shape changes and active intercalation-like cell rearrangement,
transforming a compact cord-like HPD primordium into a
mono-layered epithelial duct. EphrinB1 and EphB3b play a
crucial role in regulating these cell shape changes essential for
HPD tubulogenesis.
Non-muscle myosin activity mediates HPD lumen remodeling.
The dynamic changes in epithelial organization of the HPD
during duct differentiation and the related defects in ephrinb1
and ephb3b mutants suggest an active contribution of cytoskeletal
remodeling and actomyosin contractility to the tube maturation
process36. First, we assessed whether myosin II contractility is
required for HPD formation by incubating wild-type embryos
with the selective pMLC inhibitor blebbistatin during lumen
remodeling (Fig. 4a). Blebbistatin incubation consistently caused
luminal gaps and loops in the HPD of 60 hpf embryos
(Fig. 4b–d), reminiscent of the lumen remodeling defects
observed in ephrinb1 and ephb3b mutants. Moreover, remodeling
defects are associated with rounded and/or elongated epithelial
cells and a signiﬁcantly elongated CBD (Fig. 4e). These ﬁndings
show that myosin II contractility is required for HPD remodeling
into a mature tube, possibly contributing to multiple steps of cell
shape changes leading to the rearrangement of polarizing cells to
form a central lumen. To elucidate the function of myosin
activity, we determined its subcellular distribution. Staining
showed that actin and active non-muscle myosin II, visualized by
phosphorylation of its regulatory light chain (pMLC), are enri-
ched apically and at lower levels at lateral and likely at basal
membranes during stages of HPD remodeling (Fig. 4f). Myosin
contractility is therefore a good candidate to regulate apical
domain size in the differentiating HPD. We determined apical
pMLC levels focusing on ephrinb1 mutants, which exhibit distinct
cell shape change defects in the CBD at 60 hpf (Fig. 3f, g).
Quantiﬁcation of staining intensity showed an up to six-fold
increase of apical pMLC levels in ephrinb1 mutants compared to
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controls, suggesting hyper-contracted apical domains contribute
to the altered cell shapes in the CBD (Fig. 4f–h, Supplementary
Fig. 5). These data demonstrate that EphrinB1 contributes to
HPD cell rearrangement and lumen resolution by directly or
indirectly regulating apical pMLC levels and distribution.
EphB/EphrinB signaling is required for HPD lumen remodeling.
To distinguish whether HPD malformations in ephrinb1 and
ephb3b mutants are the result of a requirement for EphrinB1
and EphB3b in HPD remodeling or secondary to earlier
progenitor positioning defects30, we blocked EphB/EphrinB
signaling speciﬁcally during the time window of duct remodel-
ing. For this we expressed EphrinB1EC, the extracellular domain
of EphrinB1 which acts as a secreted, dominant-negative form37.
For conditional ubiquitous expression transgenic UAS:ephrin-
B1EC ﬁsh were crossed with hsp70l:Gal4 ﬁsh and the embryos
exposed to heat-shock at key stages of HPD remodeling and
assessed at 60 hpf when a single HPD lumen is established
(Fig. 5a, b). The majority of manipulated embryos display severe
morphological HPD defects upon blocking EphB/EphrinB sig-
naling around the onset of remodeling at 50 hpf or when
remodeling is ongoing at 54 hpf. Defects include luminal
loops, dysmorphic and enlarged immature luminal domains
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throughout the HPD and a severely hypoplastic or absent GB
(Fig. 5c, d). In addition, in most embryos the morphology of the
pancreas is dysmorphic, with some embryos displaying ectopic
groups of Prox1+/Hnf4α− cells that frequently appear connected
by aPKC+ ductal structures to the EPD or pancreas (Fig. 5c, d),
suggesting impaired integrity of the pancreatic epithelium and its
expansion into ectopic locations. Hence, EphB/EphrinB signaling
is required for HPD duct remodeling and EphrinB1 and EphB3b
could play multiple independent and sequential roles in liver,
pancreas and HPD development. Moreover, phenotypes upon
blocking EphB/EphrinB signaling are often more severe than
those observed in ephb3b and in particular ephrinb1 mutants
alone, supporting that additional EphrinBs and EphBs may be
involved in HPD development.
EphrinB2a and EphB4a regulate GB and CBD formation. In
light of the only partial overlap of ephrinb1 and ephb3b mutant
HPD phenotypes and the more severe malformations observed
upon blocking EphB/EphrinB signaling, we assessed the invol-
vement of additional EphrinB ligands and EphB receptors in
HPD development. First, we determined the spatial expression of
EphrinB1 and EphB3b by immunostaining. During the onset of
HPD tube formation, at 48 hpf, EphrinB1 is expressed in the liver
c d
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Fig. 5 EphB/EphrinB signaling controls HPD lumen morphogenesis independently of other morphogenetic roles. a Conditional ephrinb1EC expression is
induced by heat-shock prior to or during CBD remodeling, at 50 hpf or 54 hpf, respectively. Embryos were analysed at 60 hpf (heat-shock at 50 hpf: n= 7,
heat-shock at 54 hpf: n= 7, both N= 1). b–d Hnf4α (green), Prox1 (magenta) and aPKC (gray) labeling show that unlike in controls (b), conditional
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and at lower levels in the HPD primordium next to the liver,
whereas EphB3b shows strong expression in the pancreas and
HPD adjacent to the pancreas and weak expression adjacent to
the liver and HPD-surrounding mesenchyme (Fig. 6a). At 52 hpf
and as the HPD starts differentiating, EphrinB1 is expressed
throughout the liver and in the EHD, GB, CBD and intestinal
epithelium, while EphB3b is expressed highly in the pancreas and
at lower levels in the EPD and mesoderm surrounding the HPD
system (Fig. 6b). Given their bidirectional signaling capabilities,
this expression proﬁle suggests that EphrinB1 may interact with
EphB3 at (i) the endoderm-mesoderm interface for the EHD, GB
and CBD and (ii) within the duct at the CBD-EPD boundary
(Fig. 6b). Notably, EphrinB1 expression in ephb3b mutants
expands from the CBD into the EPD (Supplementary Fig. 7),
possibly because of the absence of EphB3b-mediated membrane
removal by endocytosis38. Alternatively, EPD cells express
EphrinB1 due to the release of repressive EphB3b effectors at the
transcriptional level.
Next, we investigated EphrinB2a and EphB4a as additional
regulators of HPD formation, since they frequently act in concert
with EphrinB1 and/or EphB3 in complex morphogenetic
processes21, such as vascular morphogenesis39, cell positioning
in the intestine40 or tissue separation27,29. To assess their
spatiotemporal expression, we generated polyclonal antibodies
revealing EphrinB2a expression in the GB primordium and at
lower levels in adjacent parts of the CBD at 52 hpf, while EphB4a
is co-expressed in the GB and non-HPD mesoderm (Fig. 6c).
Hence, these four genes are expressed in a regionalized and partly
overlapping pattern during HPD development and in differ-
entiated ducts. In addition, mammalian conservation was
suggested by expression analysis of human tissue samples,
revealing EPHRINB1, EPHRINB2, and EPHB4 expression in
large biliary ducts and EPHRINB1, EPHRINB2, EPHB3, and
EPHB4 in extrahepatic cholangiocarcinoma tissue, serving as
closest avatar, since access to healthy tissue is difﬁcult
(Supplementary Fig. 8).
To assess EphrinB2a and EphB4a functions in HPD develop-
ment, we analyzed mutants for HPD lumen formation by aPKC
staining at 60 hpf and HPD morphology by Anxa4 staining at
5 dpf. ephrinb2a mutants exhibit unresolved loop-like lumina,
both in the GB and CBD, at 60 hpf (Fig. 7c, f, Supplementary
Movie 5), and substantially smaller GBs and dysmorphic CD and
CBD at 5 dpf (Fig. 7g, i, Supplementary Movie 11). Given the
EphrinB1 and EphrinB2a co-expression in overlapping HPD
domains, we assessed their genetic relationship in double
mutants. Most ephrinb1;ephrinb2a HPD phenotypes are more
severe, including cysts in the EHD, GB and CBD region at 60 hpf,
consistent with additive phenotypes (Fig. 7b–d, f, Supplementary
Movie 6). Similarly at 5 dpf, ephrinb1; ephrinb2a double mutants
display signiﬁcantly smaller GBs and short dysmorphic EHDs
and CBDs (Fig. 7h-j, l, m, Supplementary Movie 12). ephb4a
mutants showed a transiently smaller GB primordium compared
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to unchanged liver progenitor numbers at 52 hpf (Fig. 7n–q), but
no detectable change in the HPD at 60 hpf and 5 dpf (Fig. 7e, f,
k–m, Supplementary Movies 7, 13), indicating compensation by
other factors. Likewise, ephb3b; ephb4a double mutants showed
no additional phenotypes to those of ephb3b mutants (data not
shown). Together these data demonstrate compartment-speciﬁc
expression and requirements for EphrinB1, EphrinB2a, EphB3b,
and EphB4a in HPD duct remodeling and GB formation,
revealing an EphB/EphrinB code-like control of HPD morpho-
genesis, including signaling interactions at multiple endoderm-
mesoderm and intra-endodermal tissue interfaces.
Discussion
In this study, we show that the HPD system differentiates by a
dynamic morphogenetic process, in which a mature tube forms
by a multi-step cord-hollowing mechanism. This includes
remodeling from multiple nascent lumina into a single lumen,
which requires active cell intercalation and actomyosin con-
tractility. We identify EphB/EphrinB signaling as a key regulator
of this step. Speciﬁcally, multiple EphB receptors and EphrinB
ligands are required for HPD morphogenesis in a compartment-
speciﬁc fashion. In light of the regionalized and partly over-
lapping ligand and receptor expression in the HPD endoderm
and surrounding mesoderm we propose that compartment-
speciﬁc duct remodeling is controlled by a morphogenetic EphB/
EphrinB code that involves signaling at multiple tissue interfaces
(Fig. 8a, b).
The HPD system primordium forms between the outgrowing
liver and ventral pancreas buds2,15,41 and we show that HPD
tubes form concomitant to the differentiating IHDs and IPDs.
Polarity acquisition of HPD progenitors is marked by the emer-
gence of multiple tight junction protein ZO-1 aggregates, which
subsequently mature into nascent apical aPKC+ microlumina.
Upon expansion, they connect with adjacent microlumina coa-
lescing into a continuous nascent lumen, transitioning through
intermediates of luminal loops and occasionally parallel lumina.
Our ﬁndings thus demonstrate that HPD de novo lumen for-
mation occurs by a dynamic multi-step process to generate epi-
thelial tubes by cord hollowing (Fig. 8c), similar to lumen
morphogenesis in the zebraﬁsh gut42–44 and the steps underlying
ductal plexus formation in the mouse pancreas32,33,45.
Our high-resolution analysis further revealed that cell inter-
calation is part of the cell rearrangements transforming the multi-
layered cord into a single-layered ductal epithelium. HPD
teardrop-shaped cells extend apical ﬁlopodia during lumen
remodeling similar to radial intercalation of multi-ciliated cells
into the epidermis in Xenopus46 and extending mammary gland
ductules35 corroborating the role of cell intercalation in driving
epithelial tube elongation, such as Drosophila trachea or in the
vertebrate kidney47,48, whereby the exact mode (e.g., radial,
rosette mediated) may differ.
Adding to the mechanistic understanding of cord hollowing,
we demonstrate the importance of actomyosin contractility.
Given the diverse roles of myosin II in morphogenesis, it is likely
involved in multiple steps of tubulogenesis. First, apical con-
traction by actomyosin activity controls lumen size49,50, while
inhibition leads to cell spreading. Controlled apical actomyosin
contractility may allow just enough cell spreading to ensure
fusion of nascent microlumina, while loss of contractility leads to
excessive lumen expansion. In line with this, HPD progenitors
exhibit high apical pMLC and blocking myosin II during CBD
lumen resolution results in an expanded luminal network. Con-
versely, an increase of apical pMLC levels in ephrinb1 mutant
CBDs is associated with an increase of teardrop–shaped cells and
domain shortening. This suggests that EphrinB1 promotes the
acquisition of distinct apical myosin II levels, which prevent cell
spreading and thereby ensure moderate contractility critical for
coordinated cell intercalation and balanced apical expansion
during CBD formation. We thus propose that tight spatial and
temporal control of apical membrane size is essential for lumen
coalescence in cord hollowing. Constraining lumen size by
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myosin II is important during ascidian notochord formation51,
lumen expansion in zebraﬁsh and murine blood vessel
development49,50 and branching of pancreatic ducts52. Further-
more, blocking myosin II and its localization to actin ﬁbers at the
leading edge of migrating cells53 would compromise cell inter-
calation and hence formation of a single-layered epithelial duct.
Finally, low pMLC at the lateral side of CBD cells indicates that it
may control membrane shortening, similar to ascidian endoderm
invagination54. Altogether, our data show a mechanistic link
between EphrinB1 and myosin II pathway. EphrinB1 could
directly control apical pMLC localization, or indirectly, for
instance via RhoA and ROCK, known effectors of EphB/EphrinB
signaling20. Co-expression of EphrinB1 and EphrinB2a combined
with additive CBD defects in double mutants point to similar
functions for EphrinB2a in this process. Milder cell shape defects
in ephb3b CBDs suggest that EphB3b controls tubulogenesis only
partly by EphrinB-mediated apical pMLC levels. EphB/EphrinB
signaling could further contribute to other roles in cell migration/
intercalation and/or basolateral membrane shortening during
HPD tube formation. The importance of cytoskeletal remodeling
in biliary ducts is highlighted by ductal defects in zebraﬁsh
mutants for Hippo-Yap pathway component Nf2 and the serine-
threonine kinase Cdk555,56.
Repulsion-based activity of regionalized Ephs and Ephrins is
known to coordinate complex morphogenetic developmental
processes, such as rhombomere boundary formation in the
hindbrain27 or axon guidance to generate topographic maps in
the retinotectal system21,57. During early organogenesis, EphBs
and EphrinBs direct the asymmetric migration of hepatoblasts to
their ﬁnal position30. Yet for the HPD system, we show that
regionalized EphB and EphrinB activity is required for
compartment-speciﬁc tube morphogenesis (Fig. 8a). Both the
spatiotemporal expression and mutant phenotypes suggest that
EphB/EphrinB signaling regulates HPD morphogenesis from the
onset, and early progenitor positioning may partly contribute.
This uncovers a putatively more general role of Eph/Ephrin sig-
naling in directing tube morphogenesis in complex ductal sys-
tems, because regionalized expression is reported in the mouse
kidney58. Speciﬁcally, EphB3b is required for the remodeling of
microlumina into a single lumen throughout the HPD, while
EphrinB1 controls only the remodeling of the EHB, but not the
EPD. EphB3b therefore interacts with an additional currently
unknown EphrinB ligand in EPD morphogenesis, or acts in a
ligand-independent fashion59. EphrinB2a and EphB4a regulate
GB size, either by mediating progenitor speciﬁcation, aggregation
of GB progenitors into the prospective GB primordium or by
proliferation. Therefore, regionalized members of the same gene
family ensure efﬁcient and coordinated morphogenesis of all
HPD parts, resulting in compartment-speciﬁc morphology of the
individual ducts. First insights of how these complex expression
patterns arise, come from analysis of sox9b mutants exhibiting a
mis-patterned and dysmorphic HPD system15,16. We show that
EphrinB1 expression in the CBD is reduced in 60% of sox9b
mutants (data not shown), indicating that Sox9b controls HPD
patterning and morphogenesis via independent effectors.
Given the bidirectional signaling capabilities of EphB/EphrinB
signaling, the regionalized expression of two EphrinB ligands and
two EphB receptors during HPD development allows different
signaling possibilities. EphrinB1/EphrinB2a expression in all EHB
compartments, and EphB3b expression in the EHD surrounding
mesoderm and the EPD endoderm (Fig. 8b), suggests signaling in
trans across two receptor-ligand interfaces: (i) remodeling of the
EHB ducts can be mediated by signaling across the endoderm-
mesoderm boundary, with EphrinB1/EphrinB2a reverse signaling
controlling the dynamic cell rearrangements in the ductal epi-
thelium. (ii) EphrinB1/EphB3b interactions at the CBD-EPD
boundary may regulate duct remodeling via reverse signaling in
the EphrinB1-positive CBD, and by forward signaling in the
EphB3b bearing EPD. This disruption of the CBD-EPD junction
is similar to pancreaticobiliary maljunctions of patients with two-
way reﬂux of bile and pancreatic juice, inﬂammation and meta-
plasia of ductal cells60. Notably, ductal tight junction proteins and
myosin light chain kinase are altered in these cases, corroborating
the myosin II requirement for HPD formation shown in our
study. The additive EHB defects in ephrinb1;ephrinb2a double
mutants indicate that both ligands interact with mesodermal
EphB3b, reﬂecting increased signaling strength, similar to what
has been observed in Xenopus germ layer separation29 and in line
with promiscuous ligand-receptor interactions20.
Blocking EphB/EphrinB signaling by dominant negative
EphrinB1EC expression, demonstrates that HPD lumen resolution
is speciﬁc and independent from earlier EphB/EphrinB functions
in left-right signaling or asymmetric liver progenitor
positioning30,61, revealing temporally distinct sequential roles in
organogenesis. Finally, the expression of EPHBs and EPHRINBs
in human indicates a conserved role in epithelial maintenance of
large biliary ducts and possible HPD morphogenesis across
vertebrates.
This systematic analysis describes how functional HPD tubes
form to connect the liver and pancreas to the intestine, estab-
lishing a reference for future studies of HPD development and to
further our understanding of congenital cases of HPD mal-
formation. The identiﬁcation of regionalized activity of multiple
EphrinB ligands and EphB receptors uncovers a paradigm for
coordinating the morphogenesis of multi-compartment ductal
systems and subsequent maintenance of tissue integrity.
Methods
Zebraﬁsh stocks. Adult zebraﬁsh and embryos (Danio rerio) were kept and
raised according to standard laboratory conditions62. All experiments were
performed according to ethical guidelines approved by the Danish Animal
Experiments Inspectorate (Dyreforsøgstilsynet) or the UK Home Ofﬁce under the
Animals (Scientiﬁc Procedures) Act 1986. The following strains were used: Tg
(UAS: ephrinb1EC)nim25 30, Tg(hsp70l:Gal4)fci1 (gift from David Wilkinson),
ephrinb1nim26 30, ephrinb2ahu3393 and ephb4ahu3378 (Stemple Laboratory, direct
submission to ZFIN), Tg(keratin18:GFP)p314 63 and Tg(Xla.Eef1a1:GFP)s854 41.
Generation of genetic mutants. The ephb3bnim27 mutant allele was generated by
CRISPR/Cas9 injections into one-cell-stage zebraﬁsh embryos64. A single sgRNA
targeting the sequence 5′-GGG CCA TGA CTG AGC TGG CC-3” in the second
exon of EphB3b (Supplementary Fig. 1) was created by annealing and cloning two
complementary oligonucleotides into the pDR274 backbone (Addgene #42250). In
vitro synthesis of the sgRNA was performed using the T7 RiboMAXTM Large Scale
RNA Production System (Promega). Mutations were analyzed by amplicon
restriction using the primers ephb3bF 5′-GGCCTGTTGTTTCCTCAGACT-3′ and
ephb3bR 5′-GCAAAACATGACCTTGTTGA-3′, followed by XcmI restriction and
veriﬁed by sequencing. A carrier ﬁsh transmitting a 4 bp deletion affecting the
ligand-binding domain was used to generate a stable line.
Fig. 8 An EphB/EphrinB code and myosin II contractility control HPD
tubulogenesis. a Graphic representation of domain-speciﬁc phenotypes
observed in ephrinb1, ephrinb2a, ephb3b and ephb4amutants; y-axis indicates
overall severity of phenotypes. b Graphic representation of domain-speciﬁc
expression of EphrinB1, EphrinB2a, EphB3b and EphB4a in HPD endoderm
and surrounding mesoderm at 52 hpf. c Working model of HPD de novo
lumen formation focused on the CBD domain. Lumen formation occurs by a
multi-step cord hollowing mechanism, which starts with scattered
junctional aggregates, transitions through apical/luminal pocket formation
and their subsequent coalescence and ﬁnally resolves into a single lumen.
Apical/luminal pocket coalescence is promoted by ductal EphrinB1/
EphrinB2a interaction with mesodermal EphB3b at the tissue interface and
actomyosin contractility
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Genotyping of genetic mutants. Adult mutant carriers are identiﬁed by PCR and
restriction digest-based genotyping of tailﬁn tissue. To genotype embryos for
experiments, we collected 1–2 mm of tail tissue after ﬁxation to determine the
genetic status by PCR and restriction digest. Conditions for PCR and restriction
digests are shown in Table 2.
Immunohistochemistry. Embryos are ﬁxed with 4% paraformaldehyde (PFA)
overnight at 4 °C, permeabilized with PBST (PBS with 0.1% Triton x-100) and
deyolked, followed by blocking with 1% Triton-100 and 10% donkey/goat serum in
PBS for 1 h and incubated with primary antibodies, α-2F11 (mouse monoclonal,
1:1000, gift from Julian Lewis), α-ZO1 (mouse monoclonal antibody, 1:200, Invi-
trogen, 33–9100), aPKCζ (rabbit polyclonal antibody,1:1000, Santa Cruz, sc-216),
α-pan-Cadherin (mouse monoclonal antibody, 1:1000, Sigma, C1821, rabbit α-
EphrinB130 and guinea pig α-EphB3b30 overnight at 4 °C. After repeated washing
with PBST, embryos are incubated in secondary antibodies and ﬂuorescent stains,
donkey-anti-rabbit Cy3 (1:200, Jackson Immunoresearch, 112-166-143), donkey-
anti-mouse 647 (1:400, Jackson Immunoresearch, 715-605-151), donkey-anti-goat
488 (1:200, Jackson Immunoresearch, 705-545-147) and Alexa Fluor 488 Phalloi-
din (1:500, Molecular Probes, A12379), Alexa Fluor 647 Phalloidin (1:500, Mole-
cular Probes, A22287), DAPI (1:1000, Sigma, D9542) overnight at 4 °C. For nuclear
protein detection with α-Prox1 (mouse monoclonal antibody, 1:50, Abcam,
ab33219), rabbit polyclonal antibody, 1:500, Angiobio, 11-002P) and α-Hnf4a (goat
polyclonal antibody, 1:100, Santa Cruz, sc-6556), embryos are incubated with
DNaseI enzyme at 37 °C for 45 min prior to blocking65 and washed with PBS,
followed by normal staining protocol. To detect phospho-MLC we followed Sid-
haye et al.66, we permeabilized embryos with PBST (PBS with 0.8% Triton X-100)
and trypsinized on ice for 15 min, followed by blocking with 10% goat serum and
incubation in α-pMLC (rabbit Ser19; 1:100; Cell Signaling, #3671S) 1% goat serum
in PBST for 60 h at 4 °C. After washing, the secondary antibody mix with 1% goat
serum in PBST is added for 60 h.
Polyclonal antibodies against EphrinB2a and EphB4a were generated in rabbits
and guinea pigs, respectively30. We subcloned the ectodomain region with the
native signal peptide of zebraﬁsh EphrinB2a and EphB4a into a mammalian
expression vector containing a C-terminal rat Cd4d3+ 4 tag and a hexa-his tag for
expression of a soluble recombinant protein by transient transfections into
HEK293E cells (Bushell et al., 2008). Ni2+-afﬁnity chromatography (GE
Healthcare) was used for protein puriﬁcation. The animal facility contracted to
produce antibodies is based in the UK and governed by UK legislation including
the Animal (Scientiﬁc Procedures) act 1986. This facility was regularly inspected by
the UK Home Ofﬁce and all works subject to an ethical review.
Embryos were mounted either in 4% agarose and sectioned 130 μm using a
Leica Vibratome or as whole-mount in Benzyl Alcohol, Benzyl Benzoate (BABB)
clearing mixture prior to imaging. The embryos were imaged with a Leica SP8 or a
Zeiss 780 confocal microscope. Images were processed with Imaris (Bitplane)
image analysis software and Adobe Photoshop CS.
Heat-shock experiment. Embryos collected from Tg(UAS: ephrinb1EC)nim25 and
Tg(hsp70l:Gal4)fci1 intercrosses were subjected to heat shocks at 39 °C: 45 min
either at 50 hpf or 54 hpf. The embryos were then returned to 28 °C incubator until
ﬁxation at 60 hpf.
Mosaic cell labeling by DNA injection. Membrane-targeted lyn-tdTomato under
the control of the ubiquitin (ubi) promoter was co-injected at 20–30 pg DNA/
embryo with 30–80 pg/embryo transposase mRNA into 1-cell-stage Tg(Xla.Eef1a1:
GFP)s854 embryos.
Blebbistatin treatment. Myosin II ATPase activity was inhibited by blebbistatin67.
Considering the impact of actomyosin dependent contractility in various cellular
processes, we used mild doses of the drug (65 μM of ﬁnal concentration in embryo
water). Embryos were incubated from 52 hpf until 60 hpf at 28 °C under slow
shaking conditions to prevent precipitation of the solution. This treatment caused
no apparent change to the overall embryo body phenotype.
Quantiﬁcation of phenotype severity. The variability of the mutant lumen
formation defects was quantiﬁed by scoring ductal malformations in a domain-
speciﬁc fashion. Each domain of the HPD system was assessed individually on a
scale from 0 to 2, with 0= no defect; 1=mild defect; 2= strong defect (Supple-
mentary Fig. 3a–f, Table 1). 3D-confocal stacks of aPKC immunostainings of
control and mutant HPDs were renamed for blind analysis and independently
scored by two authors. The scores were independently analyzed with the Fisher
Exact Test for frequency data. The robustness of the scoring was assessed by
comparing and averaging both sets of scores. Given they are frequency data, they
were ﬁrst converted into ordinal data and then tested with the Wilcoxon test for
non-parametric data (Supplementary Fig. 3g–j).
Cell shape analysis. To assess CBD cell shapes, the length of apical and basal cell
domains and cell height were measured in embryos, in which aPKC labeled the
apical membrane, panCadherin outlined cells and nuclear Dapi served to identify
individual cells. 3D-stacks of confocal images were processed in 2D focal sections
with Imaris (Bitplane) analysis software and cellular parameters were determined
with the Measurement plug-in. Cells with unclear boundaries or complex mem-
brane topologies possible due to contributions from multiple cells were excluded
from the analysis. Statistical signiﬁcance was assessed by unpaired Student’s t-test.
EdU incorporation assay and proliferation analysis. Embryos were incubated for
60 min at 28.5 °C in 400 μM 5-ethynyl-2’-deoxyuridine (EdU) with 15% DMSO in
egg water, and control larvae were treated with 15% DMSO. Larvae were ﬁxed after
incubation for 90 min at room temperature and processed using the Click-iT EdU
Imaging Kit (Invitrogen). EdU incorporation was quantiﬁed with Imaris analysis
software. Anxa4 antibody staining was used to mask the HPD ducts via the surface
tool. DAPI- and EdU-positive cells were counted in the masked channels by the
spot function and the ratio of EdU- to DAPI-positive cells was calculated
subsequently.
Quantiﬁcation of pMLC levels. Wild-type and ephrinb1 mutant embryos stained
for pMLC, ZO-1 and actin were used for pMLC quantiﬁcation. Using FIJI68, for
each sample three linear ROIs where drawn perpendicular to the duct luminal axis
and on a single plane, in which the lumen was clearly visible; each ROI was
10 pixels/1.9 μm wide and spanning the whole tube across opposite basal sides
(52.7 μm). Average intensities in each position of the line were extracted using the
Plot Proﬁle plugin in FIJI. A rectangular ROI of 40 μm2 was used to extract the
average background intensity in each channel and used to normalize the ﬂuores-
cence intensity values within the linear ROIs. Two regions of 2 μm each were
selected across the apical peaks in the intensity proﬁle of the ZO-1 channel and the
background-corrected pMLC values where integrated in the chosen areas for each
linear ROI (see Supplementary Fig. 5).
Microarray analyses of human tissue samples. Preprocessing of microarray data
from LEC201269, LEC2018 and normal bile duct (NBD) include background
correction, quantile normalization and log2-transformation of intensity values.
Differentially expressed genes were calculated by t-test analysis using R v3.3. All
samples were obtained with approval by the institutional review board of the
National Institutes of Health and collaborating institutions on the condition that
patients were anonymized69 and subsequently approved by the Danish ethics
committee.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the ﬁndings of this study are available within
the article and its supplementary information ﬁles or from the corresponding author
upon reasonable request. The image data generated and analyzed in this study are
available from the corresponding author upon reasonable request. A source data ﬁle for
Table 2 PCR and restriction digest information for mutant genotyping
Mutant Forward primer Reverse primer Annealing
temperature
Restriction enzyme
ephrinb1 5′-GTTTGTGTCTGGGAAGGGCTTAG-3′ 5′-TATGGTGCTGCAGGACTCGGCCTG-3′ 65 °C XcmI
(mutant: 2 fragments)
ephb3b 5′- GGCCTGTTGTTTCCTCAGACT-3′ 5′- GCAAACATGACCTTGTTGAGA-3′ 65 °C XcmI
(mutant: 2 fragments)
ephrinb2a 5′- TTTTGATCTAGAGAGAAATGCGAGT-3′ 5′- TAGAGGCGTGTCTGCTTTTGACACCTG-3′ 53 °C PshAI
(mutant: 2 fragments)
ephb4a 5′- AGGCGGAGAGAAGAAAGTCAA-3′ 5′- TGTTACCTGCATTGCCAAAGG-3′ 56 °C AlwnI
(mutant: 2 fragments)
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the quantiﬁcations shown in Figs. 1g, 2h, o, p, 3e–g, 4e, h, 7f, l, m, p and Supplementary
Figs. 3g–j and 6d, e are provided as a Source Data ﬁle.
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